CDC42 and autoinflammatory syndrome: Differently than the NOCARH and HLH responsive to anti-IFNγ caused by the p.R186C mutation in the CDC42 gene, novel additional mutations in CDC42 C-terminus region have been recently associated to a clinical autoinflammatory syndrome responsive to IL-1 inhibitors (124).